Efficacy and safety of Pembrolizumab and Lenvatinib plus Pembrolizumab for endometrial cancer in our department

DOI Web Site
  • TERADA Shinichi
    Department of Obstetrics and Gynecology, Osaka Medical and Pharmaceutical University
  • NISHIE Ruri
    Department of Obstetrics and Gynecology, Osaka Medical and Pharmaceutical University
  • TSUCHIHASHI Hiromitsu
    Department of Obstetrics and Gynecology, Osaka Medical and Pharmaceutical University
  • MORITA Natsuko
    Department of Obstetrics and Gynecology, Osaka Medical and Pharmaceutical University
  • TOJI Akihiko
    Department of Obstetrics and Gynecology, Osaka Medical and Pharmaceutical University
  • UEDA Shoko
    Department of Obstetrics and Gynecology, Osaka Medical and Pharmaceutical University
  • HASHIDA Sousuke
    Department of Obstetrics and Gynecology, Osaka Medical and Pharmaceutical University
  • MARUOKA Hiroshi
    Department of Obstetrics and Gynecology, Osaka Medical and Pharmaceutical University
  • FUJIWARA Satoe
    Department of Obstetrics and Gynecology, Osaka Medical and Pharmaceutical University
  • TANAKA Yoshimichi
    Department of Obstetrics and Gynecology, Osaka Medical and Pharmaceutical University
  • TANAKA Tomohito
    Department of Obstetrics and Gynecology, Osaka Medical and Pharmaceutical University
  • TSUNETOH Satoshi
    Department of Obstetrics and Gynecology, Osaka Medical and Pharmaceutical University
  • OHMICHI Masahide
    Department of Obstetrics and Gynecology, Osaka Medical and Pharmaceutical University

Bibliographic Information

Other Title
  • 当科における子宮体癌に対するPembrolizumab単剤療法，Lenvatinib/Pembrolizumab併用療法の使用経験
  • トウ カ ニ オケル シキュウタイ ガン ニ タイスル Pembrolizumabタンザイ リョウホウ,Lenvatinib/Pembrolizumab ヘイヨウ リョウホウ ノ シヨウ ケイケン

Search this article

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top